Protalix BioTherapeutics
PLX
#8648
Rank
NZ$0.13 B
Marketcap
$1.78
Share price
-4.35%
Change (1 day)
-38.32%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.16

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.16. In 2022 the company made an earnings per share (EPS) of -$0.48 an increase over its 2021 EPS that were of -$1.00.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.16-132.69%
2022-$0.48-51.61%
2021-$1.00342.86%
2020-$0.23-88.71%
2019-$2.00-34.74%
2018-$3.07-70.92%
2017-$10.562153.35%
2016-$0.47-146.77%
2015$1.00-287.88%
2014-$0.5310%
2013-$0.48130.77%
2012-$0.21-56.67%
2011-$0.48-46.43%
2010-$0.9136.59%
2009-$0.6632.26%
2008-$0.50-93.4%
2007-$7.601298.53%
2006-$0.54-96.59%
2005-$15.9419.32%
2004-$13.361552.65%
2003-$0.81-0%
2002-$0.81-50%
2001-$1.62233.33%
2000-$0.48-84.21%
1999-$3.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.03-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.17 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.01 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.23-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel